Skip to main content
  • About us
  • Investors
    • Français
    • English
  • Careers
  • Contact us
Choose your market:
Global
  • Global / English
  • Albania / Gjuha shqipe
  • Algeria / Français
  • Argentina / Español
  • Australia / English
  • Austria / Deutsch
  • Bahrain / English
  • Belgium / English
  • Bolivia / Español
  • Bosnia-Herzegovina / BS
  • Bosnia-Herzegovina / EN
  • Brazil / Português
  • Bulgaria / Български
  • Canada / English
  • Canada / Français
  • Chile / Español
  • China / 简体中文
  • China / English
  • Colombia / Español
  • Costa Rica / Español
  • Croatia / Hrvatski jezik
  • Croatia / English
  • Cyprus / English
  • Czech Republic / český
  • Denmark / Dansk
  • Denmark / English
  • Dominican Republic / ES
  • Ecuador / Español
  • Egypt / English
  • El Salvador / Español
  • France / Français
  • Germany / Deutsch
  • Ghana / English
  • Guatemala / Español
  • Hong Kong SAR China / English
  • Hungary / Magyar nyelv
  • India / English
  • Indonesia / English
  • Iraq / English
  • Ireland / English
  • Israel / Hebrew
  • Italy / Italiano
  • Japan / 日本語
  • Jordan / English
  • Kazakhstan / Pусский
  • Kenya / English
  • Kosovo / Gjuha shqipe
  • Kosovo / Srpski
  • Kuwait / English
  • Lebanon / English
  • Macedonia / Македонски јазик
  • Macedonia / Gjuha shqipe
  • Malaysia / English
  • México / Español
  • Montenegro / Montenegrin
  • Morocco / Français
  • Mozambique / Portuguese
  • Netherlands / Nederlands
  • Netherlands / English
  • New Zealand / English
  • Nigeria / English
  • Norway / Norsk
  • Pakistan / English
  • Panama / Español
  • Peru / Español
  • Philippines / English
  • Poland / Polski
  • Portugal / Português
  • Puerto Rico / English
  • Qatar / English
  • Romania / Română
  • Romania / English
  • Russia / Pусский
  • Saudi Arabia / English
  • Serbia / Srpski
  • Singapore / English
  • Slovakia / Slovenský
  • Slovenia / Slovenščina
  • Slovenia / English
  • South Africa / English
  • South Korea / 한국어
  • Spain / Español
  • Sweden / Svenska
  • Switzerland / English
  • Switzerland / Deutsch
  • Taiwan / English
  • Tanzania / English
  • Thailand / English
  • Tunisia / Français
  • Türkiye / Türkçe
  • UAE / English
  • Uganda / English
  • Ukraine / Українська мова
  • Ukraine / English
  • United Kingdom / English
  • United States / English
  • Venezuela / Español
  • Vietnam / English
  • Zambia / English
  • Global Opinion Polls
  • News & Events
    • All
    • News & Polls
    • Events
    • Webinars
    • Newsletter
  • Innovation & Knowledge
    • All
    • Media & Brand Communication
    • Consumer & Shopper
    • Customer Experience
    • Society
    • New Services
  • Our Solutions
    • All
  • Ipsos.Digital platform
  • ESG
  • About us
    • Who we are
    • Our history
    • Key figures
    • Our Values
    • AI at Ipsos
    • Our Code of Conduct
    • Taking responsibility
    • The Ipsos Foundation
    • Privacy & Data Protection
    • Online Data Quality Matters
    • Ipsos in the world
    • Board of Directors
    • Executive Committee
  • Investisseurs (Fr)
    • Cours de l’action
    • Communiqués de presse
    • Chiffres clés
    • Présentations
    • Gouvernance
      • Conseil d’administration
      • Comité Exécutif
      • Règlement intérieur du Conseil d'administration
      • Nos codes de conduite
      • Engagements RSE
    • Assemblées générales
    • Rapports financiers et informations réglementées
    • Calendrier
    • Journée investisseurs
  • Investors (En)
    • Share price
    • Press releases
    • Key figures
    • Presentations
    • Governance
      • Board of Directors
      • Executive Committee
      • Our Code of Conduct
      • Our Values
      • Taking responsibility
    • General meeting of Shareholders
    • Financial reports and other regulated information
    • Calendar
    • Investor Day
  • Careers
    • Careers at Ipsos
    • Generation Ipsos
  • Contact us
  • Contact us
  • Ipsos
  • Search

Search

Sort by Date Relevance
We found 529 results matching with your query. Refine by
  • Corporate

    Ipsos Healthcare Expands Syndicated Real World Evidence Offer in China

    Ipsos Healthcare has extended its syndicated Psoriasis and IBD Therapy Monitors into China. It will also re-launch the Lupus Therapy Monitor in China due to increased client demand

    27 April 2017
  • Society

    2017 US Politics - Americans Remain Pessimistic About the Current State of the Country (April 26)

    Over half of Americans (55%) still believe the country is on the wrong track, with less than a third believing we are heading in the right direction (29%).

    26 April 2017
  • Consumer & Shopper

    [EVENT] ISPOR 22nd Annual Meeting 2017

    On May 20, please join the Ipsos Healthcare team who’ll be presenting data on key topics in NASH, Oncology, Diabetes and Obesity, as well as exhibiting at the 22nd International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting.

    20 April 2017
  • Society

    2017 US Politics - Trump is Facing Important Issue Today (April 18)

    In the latest Reuters/Ipsos Core Political, many are confident in President Trump’s dealing with ISIS/ISIL and his handling of terrorism.

    18 April 2017
  • Society

    Future Cities Dialogue in the UK

    The Future Cities Dialogue engaged urban citizens in possible future urban scenarios. Citizen feedback on their preferences and priorities for future urban living is feeding into Innovate UK’s broader work on future urban systems integration and understanding and identifying the market opportunities this generates.

    10 April 2017
  • Society

    2017 US Politics - Final Quarter of President Trump’s First 100 Days (April 5)

    As we enter the final quarter of President Trump’s first 100 days, our polls show the country is no more unified or optimistic than when he took office.

    5 April 2017
  • Society

    2017 US Politics - President Trump’s approval rating breaks down: 44% approve (March 29)

    The NCAA Final Four will be played this weekend! In that spirit, we’ll be bringing you the numbers in rounds of four.

    29 March 2017
  • Consumer & Shopper

    [EVENT] PMRG Connect 2017

    On April 24, join Ipsos Healthcare at this year’s PMRG conference featuring action-oriented insights for today's healthcare research and marketing professionals. The insights landscape is rapidly evolving, and skills in triangulating diverse data sets, human emotion and healthcare decision-making remain highly desirable capabilities. Are you ready?

    24 March 2017
  • Society

    2017 US Politics - President Trump is at in a Dead Heat With 47% Approving (March 22)

    Healthcare once again beats out all other issues as the dominant concern for Americans (16%). Number two on the issues of concern list is the economy, coming in at 13%. For anyone who had “morality” in their bracket, we’re sorry to say that you’re probably not going to be pleased with the final four.

    22 March 2017
  • Society

    2017 US Politics - Healthcare Reform May Be Negatively Impacting President Trump’s Approval Rating (March 15)

    It’s unclear whether striking the word “affordable” from the Republican healthcare reform act was the cause for the lackluster public response – but the numbers, contrary to some of our polling peers, show little confidence in Speaker Ryan’s plan for the repeal and replace of Obamacare. Reuters will be releasing the exact numbers on this in the next 24 hours, so we encourage everyone to look out for that.

    15 March 2017
Pagination
  • First page 1
  • Page 10 10
  • Page 40 40
  • Previous page <
  • Current page 48
  • Next page >
  • Last page 53

Refine by

REFINE YOUR SEARCH FOR KEY WORD

  • News & Events
  • Innovation & Knowledge
    • Consumer & Shopper
    • Customer Experience
    • Media & Brand Communication
    • New Services
    • Society
  • OUR SOLUTIONS
    • Doctors & Patients
  • Citizens
  • Consumers & Brands
  • Customers & Employees
  • Doctors & Patients
  • Capabilities
  • Ipsos Encyclopedia
  • About us
  • Contact
  • Press
  • Investors
  • Careers
  • Newsletter
© 2016 - 2025 Ipsos All Rights Reserved
  • Legal Mentions
  • Privacy & Data Protection
  • Cookie policy
  • Our Alert System
  • Accessibility